Spironolactone and Perioperative Atrial Fibrillation Occurrence in Cardiac Surgery Patients.

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1500 participants.

Also called NCT03551548

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 1,500 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT03551548
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
France (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03551548. Randomized; quadruple masking; primary purpose treatment. Start 2019-02-26 (actual); primary completion 2021-07 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Spironolactone and Perioperative Atrial Fibrillation Occurrence in Cardiac Surgery Patients.
Acronym
ALDOCURE
Condition
Cardiac Surgery
Condition
Aldosterone Blockade
Intervention (Drug)
Spironolactone 25mg
Intervention (Drug)
Placebo oral capsule
Lead sponsor
University Hospital, Caen (class: other)
Collaborator
Ministry of Health, France (class: other government)

Record details

Record id
cardio:ct-nct03551548
Content hash
7a2ba71d6eab20d19f2deef16c9f9997615985396435666c59829f468d6c69a6